Format

Send to

Choose Destination
Autoimmun Rev. 2016 May;15(5):477-83. doi: 10.1016/j.autrev.2016.01.017. Epub 2016 Jan 28.

Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients.

Author information

1
School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, WA, Australia. Electronic address: p.zaenker@ecu.edu.au.
2
School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, WA, Australia.
3
School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, WA, Australia; Department of Pathology and Laboratory Medicine, The University of Western Australia, Crawley, Perth, WA, Australia.

Abstract

A link between autoimmune responses and cancer via autoantibodies was first described in the 1950s. Since, autoantibodies have been studied for their potential use as cancer biomarkers, however the exact causes of their production remain to be elucidated. This review summarizes current theories of the causes of autoantibody production in cancer, namely: 1) defects in tolerance and inflammation, 2) changes in protein expression levels, 3) altered protein structure, and 4) cellular death mechanisms. We also highlight the need for further research into this field to improve our understanding of autoantibodies as biomarkers for cancer development and progression.

KEYWORDS:

Autoantibody; Autoantibody production; Biomarker; Cancer; Humoral immune response; Immune surveillance

PMID:
26827909
DOI:
10.1016/j.autrev.2016.01.017
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center